Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study, DEVOTE, Evaluating a Higher Dose of SPINRAZA and Additional Data in a Broad Range of Patients

Leave a Comment / Clinical Trials, Research /

Biogen today announced updates to the SPINRAZA (nusinersen) clinical development program including the initiation of a new global clinical trial, DEVOTE. The DEVOTE study will evaluate if a higher dose of SPINRAZA can provide even greater efficacy in the treatment of spinal muscular atrophy (SMA) across a broad patient population. In addition, new data further […]

Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study, DEVOTE, Evaluating a Higher Dose of SPINRAZA and Additional Data in a Broad Range of Patients Read More »

2019 Summit of Strength Program Continues its Success!

Leave a Comment / Events & Fundraising, Front Page News, Support & Care /

The 2019 Cure SMA Summit of Strength Program has had a fantastic first half, with over 50 speakers sharing their expertise on numerous unique topics. We would like to thank these wonderful speakers for their participation, as well as all of the attendees for making this first half such a success. Summits are a single-day

2019 Summit of Strength Program Continues its Success! Read More »

2019 SMA Researcher Meeting Summary: Clinical Drug Development

Leave a Comment / Uncategorized /

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 attendees join together in Anaheim, CA. The goal of the meeting is to create open communication of early, unpublished data, accelerating the pace of research. The meeting also furthers research

2019 SMA Researcher Meeting Summary: Clinical Drug Development Read More »

Cure SMA Newborn Screening Registry (NBSR)

Leave a Comment / Front Page News, Support & Care /

In 2018, Spinal Muscular Atrophy (SMA) was added to the federal Recommended Uniform Screening Panel (RUSP), a panel of diseases that newborns in the United States are recommended to be screened for. However, the decision on whether to implement newborn screening for a specific condition is up to each state. Since SMA’s inclusion on the

Cure SMA Newborn Screening Registry (NBSR) Read More »

Zolgensma Update and Approval Webinars Now Available Online

Leave a Comment / Front Page News, Research, Support & Care /

A recording of last week’s webinar on Zolgensma updates is now available on Cure SMA’s YouTube channel. A presentation of the webinar can be found here. Panelists from the August 28th webinar included Dr. Peter Marks, M.D. Ph.D., Director, Center for Biologics Evaluation and Research (CBER) at FDA; Kenneth Hobby, President at Cure SMA; Mary

Zolgensma Update and Approval Webinars Now Available Online Read More »

2019 Researcher Meeting Summary: Clinical Research Studies for SMA

Leave a Comment / Front Page News, Research /

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 attendees join together in Anaheim, CA. The goal of the meeting is to create open communication of early, unpublished data, accelerating the pace of research. The meeting also furthers research

2019 Researcher Meeting Summary: Clinical Research Studies for SMA Read More »

Team Cure SMA Completes the 2019 Falmouth Road Race in Cape Cod

Leave a Comment / Events & Fundraising, Front Page News /

Twenty Team Cure SMA runners completed the 2019 Falmouth Road Race on Sunday, August 18. Together, the runners successfully raised over $52,000 for Cure SMA, the most in the race’s history for Team Cure SMA. The race celebrated its 47th annual run this year and brought more than 150 non-profit organizations together to raise money

Team Cure SMA Completes the 2019 Falmouth Road Race in Cape Cod Read More »

2019 SMA Researcher Meeting Summary: Basic Research Podium Presentations

Leave a Comment / Conference, Front Page News, Research /

The annual SMA Researcher Meeting is the largest research meeting in the world specifically focused on SMA. This year, we had a record setting 735 attendees join together in Anaheim, CA. The goal of the meeting is to create open communication of early, unpublished data, accelerating the pace of research. The meeting also furthers research

2019 SMA Researcher Meeting Summary: Basic Research Podium Presentations Read More »

Cure SMA to Host August 28th Webinar on Zolgensma Updates

Leave a Comment / Events & Fundraising /

On Wednesday, August 28th, at 12pm CST (10am PST/11 am MST/1pm EST) Cure SMA will host a webinar to provide updates on Zolgensma. The webinar will be divided into three separate sections. We’re pleased to have representatives from the FDA, Cure SMA, and AveXis, a Novartis Company, participating to share information and answer questions. Panelists

Cure SMA to Host August 28th Webinar on Zolgensma Updates Read More »

Thank You for a Wonderful 2019 Annual SMA Conference!

Leave a Comment / Conference, Front Page News /

Thank you to everyone who attended the 2019 Annual SMA Conference at the Disneyland in Anaheim, California! It was an impactful weekend of community, research and fun. We are happy to announce that, including on-site registration, there were over 2,500 attendees in total – our largest conference to date! It was such an honor to

Thank You for a Wonderful 2019 Annual SMA Conference! Read More »

Scroll to Top